N-(2-(2-Methyl-5-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)benzamido)phenoxy)ethyl)nicotinamide

ID: ALA3974870

Chembl Id: CHEMBL3974870

PubChem CID: 134154451

Max Phase: Preclinical

Molecular Formula: C29H32F3N5O3

Molecular Weight: 555.60

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1OCCNC(=O)c1cccnc1

Standard InChI:  InChI=1S/C29H32F3N5O3/c1-20-5-8-24(17-26(20)40-15-10-34-27(38)22-4-3-9-33-18-22)35-28(39)21-6-7-23(25(16-21)29(30,31)32)19-37-13-11-36(2)12-14-37/h3-9,16-18H,10-15,19H2,1-2H3,(H,34,38)(H,35,39)

Standard InChI Key:  WSPONIMLMLIHFV-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3974870

    ---

Associated Targets(Human)

KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCR/ABL BCR/ABL p210 fusion protein (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 555.60Molecular Weight (Monoisotopic): 555.2457AlogP: 4.22#Rotatable Bonds: 9
Polar Surface Area: 86.80Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.79CX Basic pKa: 7.57CX LogP: 3.75CX LogD: 3.35
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.38Np Likeness Score: -1.74

References

1. Wang Q, Liu F, Wang B, Zou F, Qi Z, Chen C, Yu K, Hu C, Qi S, Wang W, Hu Z, Liu J, Wang W, Wang L, Liang Q, Zhang S, Ren T, Liu Q, Liu J..  (2017)  Discovery of 4-Methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-yl)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge Binding.,  60  (1): [PMID:27966954] [10.1021/acs.jmedchem.6b01290]

Source